Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BURNING ROCK BIOTECH LIMITED

(BNR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Burning Rock Biotech Reports Wider Q3 Loss, Higher Revenue

11/16/2021 | 07:50am EST


ę MT Newswires 2021
All news about BURNING ROCK BIOTECH LIMITED
2021BURNING ROCK BIOTECH : Announces Results of 2021 Annual General Meeting - Form 6-K
PU
2021Burning Rock Biotech Reaffirms 2021 Revenue Target
MT
2021Burning Rock Reaffirms 2021 Revenue Guidance of RMB500 Million
AQ
2021Burning Rock Biotech Limited Provides Revenue Guidance for 2021
CI
2021Burning Rock Announces Results of 2021 Annual General Meeting
AQ
2021Oncocyte and Burning Rock Complete Technology Transfer Part Two and Prepare for Scaled ..
AQ
2021Merck KGaA, Darmstadt, Germany and Burning Rock Collaborate on Liquid-biopsy Based CDx ..
AQ
2021Health Care Stocks Mixed Pre-Bell Tuesday
MT
2021Burning Rock Biotech Reports Wider Q3 Loss, Higher Revenue
MT
2021BURNING ROCK BIOTECH : Reports Third Quarter 2021 Financial Results - Form 6-K
PU
More news
Analyst Recommendations on BURNING ROCK BIOTECH LIMITED
More recommendations
Financials
Sales 2021 505 M 79,7 M 79,7 M
Net income 2021 -391 M -61,8 M -61,8 M
Net cash 2021 1 220 M 192 M 192 M
P/E ratio 2021 -15,6x
Yield 2021 -
Capitalization 6 119 M 965 M 965 M
EV / Sales 2021 9,70x
EV / Sales 2022 8,28x
Nbr of Employees 938
Free-Float -
Chart BURNING ROCK BIOTECH LIMITED
Duration : Period :
Burning Rock Biotech Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BURNING ROCK BIOTECH LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 58,52 CNY
Average target price 157,01 CNY
Spread / Average Target 168%
EPS Revisions
Managers and Directors
Yu Sheng Han Chairman & Chief Executive Officer
Leo Li Chief Financial Officer & Director
Zhi Hong Zhang Chief Technology Officer
Shao Kun Chuai Chief Technology Officer
Wendy Hayes Independent Director
Sector and Competitors